SCHEMBL22711577

SCHEMBL22711577

C=CCn1c(=O)n(CC=C)c(=O)n(CCCCCC(C)C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.47
▸ ADORA2B P29275 4/20 0.37
▸ USP2 O75604 1/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ GAA P10253 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ ADORA2A P29274 3/20 0.34
▸ PDE4A P27815 2/20 0.34
▸ PDE4B Q07343 2/20 0.34
▸ PDE4C Q08493 2/20 0.34
▸ PDE4D Q08499 2/20 0.34
▸ PLA2G4A P47712 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MAOA P21397 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19493728 0.94 CYP3A4 (0.50) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18053449 0.93 CYP3A4 (0.57) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18106823 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18106835 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18106838 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL10960758 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18106831 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL18106818 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL11186720 0.86 CYP3A4 (0.73) CYP3A4NPSR1ADORA2BUSP2KMT2A
SCHEMBL16658922 0.86 LMNA (0.39) NPSR1ADORA2BKMT2AGAAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112011014-B Resin composition and use thereof 台燿科技股份有限公司 2022-11-22 — — CN disclosed
US-11124613-B2 Resin composition and uses of the same TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2021-09-21 — — US disclosed
US-20200377676-A1 RESIN COMPOSITION AND USES OF THE SAME TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2020-12-03 — — US disclosed
CN-112011014-A Resin composition and use thereof 台燿科技股份有限公司 2020-12-01 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11124613-B2 Resin composition and uses of the same C9, RAD51, F12 CYP3A4 1823/4885NPSR1 3453/4885ADORA2B 1725/4885
US-20200377676-A1 RESIN COMPOSITION AND USES OF THE SAME C9, RAD51, F12 CYP3A4 1823/4885NPSR1 3453/4885ADORA2B 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback